Climate change has emerged as one of the most pressing global challenges of our time, with industries across the globe reevaluating their carbon footprints. For the pharmaceutical sector, particularly Active Pharmaceutical Ingredient (API) manufacturing, sustainability is no longer an option
Decarbonization isn’t just a buzzword anymore—it’s the strategic bedrock upon which successful companies will build their future. In a world rapidly reshaping itself around climate action, proactively slashing your carbon footprint isn’t merely an environmental nicety; it’s a critical business